MICHAEL STEINMETZ
CIK 1166285 · last filed 2015-08-05
MICHAEL STEINMETZ is a corporate insider who has filed 19 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for VBIV, was dated Aug 5, 2015. Across all open-market trades the lifetime net is +$86.3M, making them a net buyer over the disclosed history. 152 SEC filings were submitted jointly with NICHOLAS GALAKATOS.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
12
19
$86.31M
Filer Profile
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VBI VACCINES INC. (VBIV) Delisted | Director | — | $0.07 | — | $0 | 1 | 2015-08-05 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2015-05-28 |
| TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Director | 4,621,423 | — | — | $89.78M | 2 | 2015-01-30 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | 10%+ Owner | 3,332,306 | $15.25 | $50.82M | $28.89M | 1 | 2013-10-28 |
| Radius Health, Inc. (RDUS) Delisted | 10%+ Owner | — | $30.00 | — | $0 | 1 | 2013-04-30 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | 10%+ Owner | 12 | — | — | $0 | 1 | 2010-12-07 |
| ReShape Weightloss Inc. (ETRM) Delisted | 10%+ Owner | 965,140 | — | — | $12.18M | 2 | 2010-10-04 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 5,364,572 | — | — | $41.60M | 3 | 2010-08-17 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 2,193,768 | — | — | -$1.50M | 1 | 2010-04-28 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 4,673,567 | — | — | -$127.0K | 1 | 2009-12-29 |
| Pharmasset Inc (VRUS) Delisted | 10%+ Owner | 8,473 | — | — | -$84.51M | 2 | 2008-06-23 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,846,599 | $1.95 | $7.50M | $0 | 2 | 2007-02-15 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-05 | VBI VACCINES INC. (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-28 | IVERIC bio, Inc. (OPHT) Delisted | Other (J) | −13,992,696 | $0 | EDGAR |
| 2015-01-30 | TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-19 | TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Mixed | +41,802,345 | $144.89M | EDGAR |
| 2013-10-28 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Mixed | +32,879,754 | $28.97M | EDGAR |
| 2013-04-30 | Radius Health, Inc. (RDUS) Delisted | Buy (P) | — | $0 | EDGAR |
| 2011-10-11 | — | Sell (S) | −3,536,400 | -$3.66M | |
| 2010-12-07 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Other (J) | −60,022,836 | $0 | EDGAR |
| 2010-10-04 | ReShape Weightloss Inc. (ETRM) Delisted | Buy (P) | — | $0 | EDGAR |
| 2010-08-17 | ARYx Therapeutics, Inc. (ARYX) Delisted | Buy (P) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.